Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fowler

Showing results (761-770 of 776) with videos related to

Pageof 78
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2014
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brainJoanna S Fowler, Jean Logan, Nora D Volkow, et al.
Ecology Letters|August 24, 2017
Boom-bust dynamics in biological invasions: towards an improved application of the conceptDavid L Strayer, Carla M D'Antonio, Franz Essl, et al.
ACS Chemical Neuroscience|September 1, 2021
Discovery of Highly Potent Adenosine A<sub>1</sub> Receptor Agonists: Targeting Positron Emission Tomography ProbesMin Guo, Abolghasem Bakhoda, Zhan-Guo Gao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2003
Low monoamine oxidase B in peripheral organs in smokersJoanna S Fowler, Jean Logan, Gene-Jack Wang, et al.
Synapse (New York, N.Y.)|May 30, 2003
Monoamine oxidase A imaging in peripheral organs in healthy human subjectsJoanna S Fowler, Jean Logan, Gene-Jack Wang, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 27, 2015
Minimizing DILI risk in drug discovery - A screening tool for drug candidatesS Schadt, S Simon, S Kustermann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 6, 2009
Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157Joanna S Fowler, Jean Logan, Albert J Azzaro, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variantsTimothy W Russell, Hermaleigh Townsley, Sam Abbott, et al.
Plos Biology|January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasionHarriet V Mears, George R Young, Theo Sanderson, et al.
The Lancet. Infectious Diseases|June 8, 2023
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infectionEdward J Carr, Mary Y Wu, Joshua Gahir, et al.
Pageof 78

Showing results (761-770 of 776) with videos related to

Sort By:
Pageof 78
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2014
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brainJoanna S Fowler, Jean Logan, Nora D Volkow, et al.
Ecology Letters|August 24, 2017
Boom-bust dynamics in biological invasions: towards an improved application of the conceptDavid L Strayer, Carla M D'Antonio, Franz Essl, et al.
ACS Chemical Neuroscience|September 1, 2021
Discovery of Highly Potent Adenosine A<sub>1</sub> Receptor Agonists: Targeting Positron Emission Tomography ProbesMin Guo, Abolghasem Bakhoda, Zhan-Guo Gao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2003
Low monoamine oxidase B in peripheral organs in smokersJoanna S Fowler, Jean Logan, Gene-Jack Wang, et al.
Synapse (New York, N.Y.)|May 30, 2003
Monoamine oxidase A imaging in peripheral organs in healthy human subjectsJoanna S Fowler, Jean Logan, Gene-Jack Wang, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 27, 2015
Minimizing DILI risk in drug discovery - A screening tool for drug candidatesS Schadt, S Simon, S Kustermann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 6, 2009
Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157Joanna S Fowler, Jean Logan, Albert J Azzaro, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variantsTimothy W Russell, Hermaleigh Townsley, Sam Abbott, et al.
Plos Biology|January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasionHarriet V Mears, George R Young, Theo Sanderson, et al.
The Lancet. Infectious Diseases|June 8, 2023
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infectionEdward J Carr, Mary Y Wu, Joshua Gahir, et al.
Pageof 78